[
  {
    "ts": null,
    "headline": "Teladoc (TDOC) Reports Q2 Loss, Beats Revenue Estimates",
    "summary": "Teladoc (TDOC) delivered earnings and revenue surprises of +29.63% and +1.77%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=4bd43da272c60759933b30ef0d585a2b8673c173865b12e624085ea3f166051a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753826701,
      "headline": "Teladoc (TDOC) Reports Q2 Loss, Beats Revenue Estimates",
      "id": 136130401,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Teladoc (TDOC) delivered earnings and revenue surprises of +29.63% and +1.77%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=4bd43da272c60759933b30ef0d585a2b8673c173865b12e624085ea3f166051a"
    }
  },
  {
    "ts": null,
    "headline": "Cencora Inc. stock outperforms competitors on strong trading day",
    "summary": "Cencora Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=348b6c6fdb914c4a6f4ea7a8b636e9dc4bffe30530e67ee162b55a0dde2abf53",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753807620,
      "headline": "Cencora Inc. stock outperforms competitors on strong trading day",
      "id": 136140511,
      "image": "",
      "related": "COR",
      "source": "MarketWatch",
      "summary": "Cencora Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=348b6c6fdb914c4a6f4ea7a8b636e9dc4bffe30530e67ee162b55a0dde2abf53"
    }
  },
  {
    "ts": null,
    "headline": "WGS Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 Sales View",
    "summary": "GeneDx reports strong Q2 results with record revenues and surging profits. A raised 2025 sales outlook fuels a 26% stock jump.",
    "url": "https://finnhub.io/api/news?id=7cb0ee09c79a1db7c9c6ea7afba6de3ee353eae1d04b493b83febff3a830370b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753796940,
      "headline": "WGS Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 Sales View",
      "id": 136119344,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "GeneDx reports strong Q2 results with record revenues and surging profits. A raised 2025 sales outlook fuels a 26% stock jump.",
      "url": "https://finnhub.io/api/news?id=7cb0ee09c79a1db7c9c6ea7afba6de3ee353eae1d04b493b83febff3a830370b"
    }
  },
  {
    "ts": null,
    "headline": "Are Medical Stocks Lagging  McKesson (MCK) This Year?",
    "summary": "Here is how McKesson (MCK) and Cencora (COR) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=47464bee180a616680b289d43c21514ab54774dcec3b09e43ba40f8e762178da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753796403,
      "headline": "Are Medical Stocks Lagging  McKesson (MCK) This Year?",
      "id": 136119480,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Here is how McKesson (MCK) and Cencora (COR) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=47464bee180a616680b289d43c21514ab54774dcec3b09e43ba40f8e762178da"
    }
  },
  {
    "ts": null,
    "headline": "Will SYK's Q2 Earnings Reflect Strong Growth Despite Tariff Overhang?",
    "summary": "Stryker's second-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs and tariffs are likely to have continued to hurt margins.",
    "url": "https://finnhub.io/api/news?id=1ff9ac176ab37f73e1a84dbca5e27626c9aeb54c7007e611a6352223baecbea1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753793640,
      "headline": "Will SYK's Q2 Earnings Reflect Strong Growth Despite Tariff Overhang?",
      "id": 136119361,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Stryker's second-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs and tariffs are likely to have continued to hurt margins.",
      "url": "https://finnhub.io/api/news?id=1ff9ac176ab37f73e1a84dbca5e27626c9aeb54c7007e611a6352223baecbea1"
    }
  },
  {
    "ts": null,
    "headline": "LTNC's LOCK'DIN Partners with Fortune 10 Leader Cencora; Portion of Proceeds to Benefit Manny Pacquiao Foundation",
    "summary": "JACKSON, WY / ACCESS Newswire / July 29, 2025 /Labor Smart, Inc. (OTCID:LTNC), a Wyoming‑based publicly traded company, today announced a landmark partnership for its functional hydration brand LOCK'DIN® with Cencora, one of the world's largest pharmaceutical ...",
    "url": "https://finnhub.io/api/news?id=b4624aa352917820740b65f7a3a9c9793be5bc26b68f25eefa1a493b6c60db91",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753792200,
      "headline": "LTNC's LOCK'DIN Partners with Fortune 10 Leader Cencora; Portion of Proceeds to Benefit Manny Pacquiao Foundation",
      "id": 136119631,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "JACKSON, WY / ACCESS Newswire / July 29, 2025 /Labor Smart, Inc. (OTCID:LTNC), a Wyoming‑based publicly traded company, today announced a landmark partnership for its functional hydration brand LOCK'DIN® with Cencora, one of the world's largest pharmaceutical ...",
      "url": "https://finnhub.io/api/news?id=b4624aa352917820740b65f7a3a9c9793be5bc26b68f25eefa1a493b6c60db91"
    }
  },
  {
    "ts": null,
    "headline": "Henry Schein to Report Q2 Earnings: What's in Store for the Stock?",
    "summary": "HSIC eyes modest Q2 gains, with dental, medical and specialty segments showing signs of steady momentum.",
    "url": "https://finnhub.io/api/news?id=fb57cc50ec73a8476a3e7acd5c7d328db8aab9449a5222d44d381543b8ae607d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753790820,
      "headline": "Henry Schein to Report Q2 Earnings: What's in Store for the Stock?",
      "id": 136119632,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "HSIC eyes modest Q2 gains, with dental, medical and specialty segments showing signs of steady momentum.",
      "url": "https://finnhub.io/api/news?id=fb57cc50ec73a8476a3e7acd5c7d328db8aab9449a5222d44d381543b8ae607d"
    }
  }
]